Physicians

Teresa C Gentile, MD, PhD

Teresa C Gentile, MD, PhD
Appointed 07/01/89
Women's Health Network
2270 Regional Oncology Center
750 East Adams Street
Syracuse, NY 13210
315 464-4353

Current Appointments

Hospital Campus

  • Downtown

Clinical Section Affiliations

  • Medicine: Hematology and Oncology
  • Upstate Cancer Center: Medical Oncology

Research Programs and Affiliations

  • Cancer Research Institute
  • Medicine

Clinic/Unit

Education & Fellowships

  • Residency: University Hospital, SUNY Health Science Center at Syracuse, 1993
  • MD: SUNY Health Science Center at Syracuse, 1989

Research Interests

  • Bone Marrow/Stem Cell Transplant, Hematologic Malignancies

Clinical Trials

  • Alliance A041202 - A Randomized Phase III Study of Bendamustine Plus Rituximab Versus Ibrutinib Plus Rituximib Versus Ibrutinib Alone in Untreated Older Patients (>= 65 Years of Age) with Chronic Lymphocytic Leukemia
    Read more
  • Allogeneic Hematopoietic Stem Cell Transplatation for CLL, CML, AML, ALL, Myelodysplasia and Non-Hodgkin's Lymphoma after Total Body Irradiation and Cyclophosphamide Conditioning or Cyclophosphamide and ATG Conditioning For Aplastic Anemia.
    Read more
  • Allogeneic Peripheral Blood Stem Cell Transplant Utilizing Non-Myeloablative Conditioning Therapy. A Phase II Study.
    Read more
  • Autologous Hematopoietic Stem Cell and/or Bone Marrow Transplantation after High Dose Chemotherapy (Carboplatinum, Etoposide) in Patients with Recurrent/Refractory Germ Cell Tumors.
    Read more
  • Autologous Hematopoietic Stem Cell Transplantation After Melphalan with or without Total Body Irradiation for Multiple Myeloma.
    Read more
  • Autologous Stem Cell Transplantation for Acute Myeloid Leukemia in First or Second Remission.
    Read more
  • CALGB #8461 - Cytogenetic Studies in Acute Leukemia
    Read more
  • CALGB 50801-Phase II Trial of Response-Adapted Therapy Based on Positron Emission Tomography (PET) for Bulky Stage I And Stage II Classical Hodgkin Lymphoma (HL)
    Read more
  • CALGB 50904-A Randomized Phase II Trial of Ofatumumab and Bendamustine vs. Ofatumumab, Bortezomib (NSC # 681239, IND # 58443) and Bendamustine in Patients With Untreated Follicular Lymphoma
    Read more
  • ECOG E1412 - Randomized Phase II Open Label Study of Lenalidomide R-CHOP (R2CHOP) vs RCHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone) in Patients with Newly Diagnosed Diffuse Large B Cell Lymphoma.
    Read more
  • High Dose Cyclophosphamide, BCNU, Etoposide & Autologous Hematopoietic Stem Cell Transplantation for Resistant & Relapsed Hodgkin's Disease.
    Read more
  • High Dose Cyclophosphamide, Thiotepa & Etoposide Followed by Autologous Hematopoietic Stem Cell Transplantation (Intermediate & High Grade).
    Read more
  • MSKCC: Autologous Stem Cell Transplant With Pomalidomide (CC-4047®) Maintenance Versus Continuous Clarithromycin/ Pomalidomide / Dexamethasone Salvage Therapy in Relapsed or Refractory Multiple Myeloma: A Phase 2 Open-Label Randomized Study by Tristate Consortium
    Read more

Specialties & Certification

  • Internal Medicine
  • Medical Oncology
  • Hematology

Diseases & Conditions Treated

  • Adult Leukemia
  • Adult Lymphoma
  • All Cancers and Hematological Conditions
  • Kidney Cancer
  • Multiple Myeloma
  • Myelodysplasia (MDS)

Treats

  • Adults

Treatments/Services

  • Apheresis
  • Blood Transfusion
  • Bone Marrow Aspiration
  • Bone Marrow Biopsy
  • Bone Marrow Transplantation (BMT)
  • Chemotherapy
  • Conscious Sedation
  • Infusional Therapies
  • Lumbar Puncture
  • Paracentesis
  • Stem Cell Collection Procedures
  • Stem Cell Transplantation
  • Thoracentesis

Current Hospital Privileges

  • Upstate University Hospital

Publications

Link to PubMed External Icon (Opens new window. Close the PubMed window to return to this page.)

Clinical Profile Shortcut: http://www.upstate.edu/findadoc/gentilet
Faculty Profile Shortcut: http://www.upstate.edu/faculty/gentilet